NEI to test Lucentis and Avastin for treating eye disorder

10/2/2006 | Bloomberg

The National Eye Institute may test Genentech's eye drug Lucentis and its cancer drug Avastin to compare the two in treating age-related macular degeneration. However, the institute said some major funding issues remain in creating the trial.

View Full Article in:

Bloomberg

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Compliance and Ethics Director
Sysmex America, Inc.
Lincolnshire, IL
Director, Site Quality Management
CareFusion
Palm Springs, CA
Compliance Officer-Medical Products
W. L. Gore
Flagstaff, AZ
Director, Site Quality Management
CareFusion
Minneapolis, MN
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC